Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells

Expert Opinion on Drug Delivery

Volumn 10, Issue 10, 2013, Pages 1345-1352

  Coelho, Sílvia Castro ^a   Rocha, Sandra ^b   Juzenas, Petras ^c   Sampaio, Paula ^d   Almeida, Gabriela M ^a   Silva, Filipe Santos ^a,e,f   Pereira, Maria Carmo ^a   Coelho, Manuel A N ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF PORTO   (Portugal)

^e University of Porto   (Portugal)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Gold nanoparticles; Pancreatic cells; Proteasome inhibitor

Indexed keywords

BORTEZOMIB; GOLD NANOPARTICLE; MACROGOL; PROTEASOME INHIBITOR;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG UPTAKE; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; EPITHELIAL CELLS; GOLD; HUMANS; NANOPARTICLES; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; PROTEASOME INHIBITORS; PYRAZINES; TUMOR CELLS, CULTURED;

EID: 84884543170     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.827659     Document Type: Article

References (27)

1. Kim JA, Aberg C, Salvati A, Dawson KA. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 2012;7(1):62-8
2. Parveen S, Misra R, Sahoo SK. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012;8(2):147-66
3. Wen J, Betty YSK, James TR, Warren CWC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008;3(3):145-50
4. Yang F, Jin C, Subedi S, et al. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Cancer Treat Rev 2012;38(6):566-79
5. Patra CR, Verma R, Kumar S, et al. Fabrication of Gold Nanoparticle for Potential Application in Multiple Myeloma. J Biomed Nanotechnol 2008;4(4):499-507
6. Moran C, Wainerdi S, Cherukuri T, et al. Size-dependent joule heating of gold nanoparticles using capacitively coupled radiofrequency fields. Nano Res 2009;2(5):400-5
7. Duncan B, Kim C, Rotello VM. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release 2010;148(1):122-7
8. Stone J, Jackson S, Wright D. Biological applications of gold nanorods. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3(1):100-9
9. Manju S, Sreenivasan K. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: Blood compatibility evaluation and targeted drug delivery onto cancer cells. J Colloid Interface Sci 2012;368(1):144-51
10. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 2010;62(3):346-61
11. Huang H-C, Barua S, Sharma G, et al. Inorganic nanoparticles for cancer imaging and therapy. J Control Release 2011;155(3):344-57
12. Yeh Y-C, Creran B, Rotello VM. Gold nanoparticles: Preparation, properties, and applications in bionanotechnology. Nanoscale 2012;4(6):1871-80
13. Aziz MS, Suwanpayak N, Jalil MA, et al. Gold nanoparticle trapping and delivery for therapeutic applications. Int J Nanomedicine 2012;7:11-17
14. Han G, Ghosh P, Rotello VM. Multi-functional gold nanoparticles for drug delivery. Adv Exp Med Biol 2007;620:48-56
15. Patra CR, Bhattacharya R, Wang E, et al. Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent. Cancer Res 2008;68(6):1970-8
16. Khan JA, Kudgus RA, Szabolcs A, et al. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS ONE 2011;6(6):27
17. Canfield SE, Zhu K, Williams SA, McConkey DJ. Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells. Mol Cancer Ther 2006;5(8):2043-50
18. Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ. The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 2004;3(1):59-70
19. Kimling J, Maier M, Okenve B, et al. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 110 (32):15700-7
20. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951;11:55-75
21. Baptista P, Doria G, Henriques D, et al. Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles. J Biotechnol 2005;119(2):111-17
22. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006;1(3):1112-16
23. Skehan P, Storeng R, Scudiero D, et al. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J Natl Cancer Inst 1990;82(13):1107-12
24. Monks A, Scudiero D, Skehan P, et al. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. J Natl Cancer Inst 1991;83(11):757-66
25. Kah JC, Olivo MC, Lee CG, Sheppard CJ. Molecular contrast of EGFR expression using gold nanoparticles as a reflectance-based imaging probe. Mol Cell Probes 2008;22(1):14-23
26. Arnida Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: A comparative study of rods and spheres. J Appl Toxicol 2010;30(3):212-17
27. Cho EC, Zhang Q, Xia Y. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 2011;6(6):385-91